Moreover, low TP63 expression (p = 0.0012), high ATF6 expression (p = 0.0055) and high GRP78 expression (p = 0.0014) were significantly associated with poor prognosis in breast cancer patients (Fig. 6D). This evidence concerns the gene ATF6 and breast cancer.